Press Releases OncoCyte Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 13:54:46 2024-05-01 EDT			5-day change	1st Jan Change
2.51 ^USD	+0.80%		+1.63%	0.00%

04-25	OncoCyte Corporation announced that it has received $15.8 million in funding	CI
04-16	Broadwood Capital, Inc. Engages with OncoCyte Corporation	CI

ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	04-15	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	04-15	AQ
Oncocyte Reports Full Year 2023 Financial Results	04-12	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	04-11	AQ
Oncocyte : and Bio-Rad Partner on Global Launch of Transplant Assay - Form 8-K	04-11	PU
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	04-11	AQ
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results	04-09	AQ
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico	01-16	AQ
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays	12-06	AQ
OncoCyte: Q3 Earnings Snapshot	11-09	AQ
Oncocyte Reports Third Quarter 2023 Financial Results	11-09	AQ
Oncocyte to Announce Third Quarter 2023 Financial Results	11-03	AQ
OncoCyte : Change in Certifying Accountants - Form 8-K	23-10-05	PU
Oncocyte : Investor Presentation	23-10-03	PU
ONCOCYTE'S VITAGRAFTTM KIDNEY IDENTIFIES TRANSPLANT REJECTION 10 MONTHS EARLIER	23-09-19	AQ
Oncocyte : Investor Presentation	23-08-21	PU
OncoCyte: Q2 Earnings Snapshot	23-08-10	AQ
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients	23-07-25	AQ
Oncocyte Announces 1-For-20 Reverse Stock Split	23-07-24	AQ
Oncocyte Begins Manufacturing Transplant Blood Test	23-06-27	AQ

No results for this search